Wormwood (Artemisia absinthium) for poorly responsive early-stage IgA nephropathy: A pilot uncontrolled trial

American Journal of Kidney Diseases

Volumn 56, Issue 6, 2010, Pages 1095-1099

  Krebs, Simone ^a   Omer, Bilal ^b   Omer, Talib Noor ^a   Fliser, Danilo ^c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c SAARLAND UNIVERSITY   (Germany)

Author keywords

IgA; Seda Leukin; Wormwood for immunoglobulin A (IgA) nephropathy

Indexed keywords

ARTEMISIA ABSINTHIUM EXTRACT;

ADULT; ARTEMISIA ABSINTHIUM; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY FUNCTION; MALE; MEAN ARTERIAL PRESSURE; PATIENT SELECTION; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ARTEMISIA ABSINTHIUM; BLOOD PRESSURE; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, IGA; HUMANS; MALE; PHYTOTHERAPY; PILOT PROJECTS; PLANT PREPARATIONS; PROTEINURIA; RENIN-ANGIOTENSIN SYSTEM; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 78649451523     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2010.06.025     Document Type: Article

References (19)

1. H.N. Reich, S. Troyanov, J.W. Scholey, and D.C. Cattran Remission of proteinuria improves prognosis in IgA nephropathy J Am Soc Nephrol 18 2007 3177 3183
2. M. MacKinnon, S. Shurraw, A. Akbari, G. Knoll, J. Jaffey, and H. Clark Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data Am J Kidney Dis 48 1 2009 8 20
3. J.J. Dillon Fish oil therapy for IgA nephropathy: efficacy and interstudy variability J Am Soc Nephrol 8 1997 1739 1744
4. L.F. Yu, X.M. Chen, and L.Q. Bo Tumor necrosis factor alpha in IgA nephropathy Zhonghua Nei Ke Za Zhi 32 5 1993 322 323
5. K.N. Lai, J.C. Leung, and L.Y. Chan Activation of podocytes by mesangial-derived TNF-α glomerulo-podocytic communication in IgA nephropathy Am J Physiol Renal Physiol 294 2008 F945 F955
6. L.Y. Chan, J.C. Leung, A.W. Tsng, S.C. Tang, and K.N. Lai Activation of tubular epithelial cells by mesangial-derived TNF-α glomerulo-tubular communication in IgA nephropathy Kidney Int 67 2005 602 612
7. J.C. Leung, S.C. Tang, L.Y. Chan, and K.N. Lai Synthesis of TNF-alpha by mesangial cells cultured with polymeric anionic IgArole of MAPK and NF-kappaB Nephrol Dial Transplant 23 1 2008 72 81
8. G.T. Sakellariou, P. Vounotrypidis, and C. Berberidis Infliximab treatment in two patients with psoriatic arthritis and secondary IgA nephropathy Clin Rheumatol 26 2007 1132 1133
9. H.N. Koo, S.H. Hong, and H.J. Jeong Inhibitory effect of Artemisia capillaris on ethanol-induced cytokines (TNF-alpha, IL-1alpha) secretion in Hep G2 cells Immunopharmacol Immunotoxicol 24 3 2002 441 453
10. H.G. Lee, H. Kim, and W.K. Oh Tetramethoxy hydroxyflavone p7F down-regulates inflammatory mediators via the inhibition of nuclear factor kappaB Ann N Y Acad Sci 1030 2004 555 568
11. S. Krebs, T.N. Omer, and B. Omer Wormwood (Artemisia absinthium) suppresses tumour necrosis factor alpha and accelerates healing in patients with Crohn's diseasea controlled trial Phytomedicine 17 2010 305 309
12. B. Omer, S. Krebs, H. Omer, and T.O. Noor Steroid-sparing effect of wormwood (Artemisia absinthium) in Crohn's disease: a double-blind placebo-controlled study Phytomedicine 14 2-3 2007 87 95
13. I.A. Khan, and E.A. Abourashed Encyclopaedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics 2nd ed. 1996 John Wiley & Sons New York, NY 1 3
14. W. Kern, H.J. Roth, and W. Schmidt Artemisia absinthium P.H. List, L. Hoerhammer, Hager's Handbuch der Pharmazeutischen Praxis fr Apotheker, Arzneimittelhersteller, rzte und Medizinalbeamte Vol 3 1973 Springer-Verlag Berlin, Germany 254 259
15. T. Muto, T. Watanabe, M. Okamura, M. Moto, Y. Kashida, and K. Mitsumori Thirteen-week repeated dose toxicity study of wormwood (Artemisia absinthium) extract in rats J Toxicol Sci 28 2004 471 478
16. S. Kuester, O. Mehls, C. Seidel, and E. Ritz Blood pressure in minimal change and other types of nephrotic syndrome Am J Nephrol 10 suppl 1 1990 76 80
17. N. MacDonald Cancer cachexia and targeting chronic inflammation: a unified approach to cancer treatment and palliative/supportive care J Support Oncol 5 2007 157 162
18. S. Hatziieremia, A.I. Gray, V. Ferro, A. Paul, and R. Plevin The effects of cardamonin on lipopolysaccharide-induced inflammatory protein production and MAP kinase and NFB signalling pathways in monocytes/macrophages Br J Pharmacol 149 2006 188 198
19. J.H. Lee, H.S. Jung, and P.M. Giang Blockade of nuclear factor-kappaB signaling pathway and anti-inflammatory activity of cardamomin, a chalcone analog from Alpinia conchigera J Pharmacol Exp Ther 316 2006 271 277